CVET Covetrus Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CVET

Price (delayed)

$20.68

Market cap

$2.88B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.3

Enterprise value

$3.81B

Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners to drive improved health and financial outcomes. The company is bringing together products, services, and technology into ...

Highlights
The net income has increased by 26% QoQ
Covetrus's EPS has increased by 23% from the previous quarter
CVET's quick ratio is down by 18% year-on-year and by 8% since the previous quarter
Sector: Healthcare
Industry: Health Information Services
Website: http://www.covetrus.com
Peers: IDXX

Key stats

What are the main financial stats of CVET
Market
Shares outstanding
139.41M
Market cap
$2.88B
Enterprise value
$3.81B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.87
Price to sales (P/S)
0.62
EV/EBIT
N/A
EV/EBITDA
19.96
EV/Sales
0.83
Earnings
Revenue
$4.62B
EBIT
-$11M
EBITDA
$191M
Free cash flow
$71M
Per share
EPS
-$0.3
Free cash flow per share
$0.51
Book value per share
$11.06
Revenue per share
$33.49
TBVPS
$12.96
Balance sheet
Total assets
$3.47B
Total liabilities
$1.92B
Debt
$1.05B
Equity
$1.53B
Working capital
$655M
Liquidity
Debt to equity
0.69
Current ratio
1.86
Quick ratio
0.98
Net debt/EBITDA
4.87
Margins
EBITDA margin
4.1%
Gross margin
18.9%
Net margin
-0.9%
Operating margin
-0.3%
Efficiency
Return on assets
-1.2%
Return on equity
-2.6%
Return on invested capital
-0.6%
Return on capital employed
-0.4%
Return on sales
-0.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CVET stock price

How has the Covetrus stock price performed over time
Intraday
-0.05%
1 week
0.24%
1 month
-0.39%
1 year
-25.8%
YTD
3.56%
QTD
23.17%

Financial performance

How have Covetrus's revenue and profit performed over time
Revenue
$4.62B
Gross profit
$873M
Operating income
-$14M
Net income
-$40M
Gross margin
18.9%
Net margin
-0.9%
Covetrus's operating margin has surged by 75% YoY and by 40% QoQ
CVET's operating income has soared by 74% year-on-year and by 39% since the previous quarter
The net income has increased by 26% QoQ
The net margin has grown by 25% from the previous quarter

Growth

What is Covetrus's growth rate over time

Valuation

What is Covetrus stock price valuation
P/E
N/A
P/B
1.87
P/S
0.62
EV/EBIT
N/A
EV/EBITDA
19.96
EV/Sales
0.83
Covetrus's EPS has increased by 23% from the previous quarter
Covetrus's revenue has increased by 6% YoY
The P/S is 3.3% more than the last 4 quarters average of 0.6

Efficiency

How efficient is Covetrus business performance
The company's return on invested capital has shrunk by 127% YoY but it has surged by 50% QoQ
Covetrus's ROS has plunged by 122% YoY but it has soared by 60% from the previous quarter
The return on equity has increased by 28% since the previous quarter
The ROA has grown by 25% from the previous quarter

Dividends

What is CVET's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CVET.

Financial health

How did Covetrus financials performed over time
CVET's total assets is 81% greater than its total liabilities
CVET's quick ratio is down by 18% year-on-year and by 8% since the previous quarter
The current ratio has declined by 11% year-on-year and by 4.1% since the previous quarter
The debt is 31% less than the equity
The debt has contracted by 2.2% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.